PortalForschendeFriedrich Haag

Prof. Dr. ID: 47531

Friedrich Haag

Verbindungen anzeigen
Einrichtung

Publikationen

CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells

Publikation: Forschung - Begutachtung › SCORING: Zeitschriftenaufsätze

CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells

Publikation: Forschung - Begutachtung › SCORING: Zeitschriftenaufsätze

CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes

Publikation: Forschung - Begutachtung › SCORING: Zeitschriftenaufsätze

Monitoring Expression and Enzyme Activity of Ecto-ARTCs

Publikation: Forschung - Begutachtung › SCORING: Zeitschriftenaufsätze

Monitoring the Sensitivity of T Cell Populations Towards NAD Released During Cell Preparation

Publikation: Forschung - Begutachtung › SCORING: Beiträge in Sammelwerken

Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity

Publikation: Forschung › SCORING: Reviews

Ecto-ADP-ribosyltransferase ARTC2.1 functionally modulates FcγR1 and FcγR2B on murine microglia

Publikation: Forschung - Begutachtung › SCORING: Zeitschriftenaufsätze

Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38+ tumors in mouse models in vivo

Publikation: Forschung - Begutachtung › SCORING: Zeitschriftenaufsätze

Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression

Publikation: Forschung - Begutachtung › SCORING: Zeitschriftenaufsätze

A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation

Publikation: Forschung - Begutachtung › SCORING: Zeitschriftenaufsätze

Alle anzeigen (80)